Volitionrx (VNRX) EBT Growth (1y) (2013 - 2025)
Volitionrx (VNRX) EBT Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 103.34% |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - | -49.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.54% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | -59.81% |
| Mar 31, 2025 | 32.91% |
| Dec 31, 2024 | 105.88% |
| Sep 30, 2024 | 99.49% |
| Jun 30, 2024 | 100.74% |
| Mar 31, 2024 | 8.16% |
| Dec 31, 2023 | -9,442.17% |
| Sep 30, 2023 | -13,369.88% |
| Jun 30, 2023 | -12,376.02% |
| Mar 31, 2023 | -11,572.83% |
| Dec 31, 2022 | 28.74% |
| Sep 30, 2022 | 53.79% |
| Jun 30, 2022 | 73.13% |
| Mar 31, 2022 | 791.10% |
| Dec 31, 2021 | 207.31% |
| Sep 30, 2021 | 459.81% |
| Jun 30, 2021 | 722.62% |
| Mar 31, 2021 | 100.16% |